Hirano Tsunahiko, Takahashi Shun, Fukatsu-Chikumoto Ayumi, Yasuda Kasumi, Ishida Takuya, Donishi Tomohiro, Suga Kazuyoshi, Doi Keiko, Oishi Keiji, Ohata Shuichiro, Murata Yoriyuki, Yamaji Yoshikazu, Asami-Noyama Maki, Edakuni Nobutaka, Kakugawa Tomoyuki, Matsunaga Kazuto
Department of Respiratory Medicine and Infectious Disease, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan.
Department of Psychiatry, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
J Clin Med. 2024 Jun 19;13(12):3589. doi: 10.3390/jcm13123589.
: COPD patients who are frail have been reported to develop brain atrophy, but no non-invasive diagnostic tool has been developed to detect this condition. Our study aimed to explore the diagnostic utility of the Kihon Checklist (KCL), a frailty questionnaire, in assessing hippocampal volume loss in patients with COPD. : We recruited 40 COPD patients and 20 healthy individuals using the KCL to assess frailty across seven structural domains. Hippocampal volumes were obtained from T1-weighted MRI images, and ROC analysis was performed to detect hippocampal atrophy. : Our results showed that patients with COPD had significantly greater atrophic left hippocampal volumes than healthy subjects ( < 0.05). The univariate correlation coefficient between the left hippocampal volume and KCL (1-20), which pertains to instrumental and social activities of daily living, was the largest (ρ = -0.54, < 0.0005) among the KCL subdomains. Additionally, both KCL (1-25) and KCL (1-20) demonstrated useful diagnostic potential (93% specificity and 90% sensitivity, respectively) for identifying individuals in the lowest 25% of the left hippocampal volume (AUC = 0.82). : Our study suggests that frailty questionnaires focusing on daily vulnerability, such as the KCL, can effectively detect hippocampal atrophy in COPD patients.
据报道,体弱的慢性阻塞性肺疾病(COPD)患者会出现脑萎缩,但尚未开发出用于检测这种情况的非侵入性诊断工具。我们的研究旨在探讨虚弱问卷“基洪检查表”(KCL)在评估COPD患者海马体体积损失方面的诊断效用。
我们招募了40名COPD患者和20名健康个体,使用KCL从七个结构领域评估虚弱程度。从T1加权MRI图像中获取海马体体积,并进行ROC分析以检测海马体萎缩。
我们的结果表明,COPD患者左侧海马体萎缩体积明显大于健康受试者(<0.05)。在KCL子领域中,左侧海马体体积与涉及日常生活工具性和社交活动的KCL(1 - 20)之间的单变量相关系数最大(ρ = -0.54,<0.0005)。此外,KCL(1 - 25)和KCL(1 - 20)在识别左侧海马体体积最低的25%个体方面均显示出有用的诊断潜力(特异性分别为93%和90%,敏感性分别为90%)(AUC = 0.82)。
我们的研究表明,像KCL这样关注日常脆弱性的虚弱问卷可以有效检测COPD患者的海马体萎缩。